Annual Report

Overview

The report presents Mankind Pharma's FY24 performance, including INR 10,335 crore of revenue and a workforce of 23,279 employees. It highlights a 52% renewable-energy share, 85% carbon-emissions reduction versus FY23, 9,417 MT of waste generated and extensive water-recycling initiatives. The company also reports expanded healthcare access and CSR programmes across communities. Its BRSR Core disclosures were independently assessed by TUV India Private Limited under reasonable assurance using ISAE 3000 (Revised).

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023-2024
Period: 1 April 2023 – 31 March 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services